News & articles

  • What to Know About the FDA Approval of momelotinib

    MPN Research Foundation is pleased to share the news of the US FDA approval of momelotinib for the treatment of myelofibrosis patients with anemia whether they have had prior treatment or not. Let’s break down what the approval of this new drug means for those impacted by MPNs: • Treatment options are expanding. Janus kinase (JAK) inhibitors… Read More »What to Know About the FDA Approval of momelotinib

    READ MORE

    Q&A with MPN Pioneer Andrew Schafer, MD

    “From the outset, we recognized that outstanding care of MPN patients required not just hematologists (who would be their primary doctors) but also the participation of other specialists who had expertise in the complications of MPNs, such as cardiologists, neurologists, vascular surgeons, interventional radiologists, dermatologists, infectious disease specialists, gastroenterologists, and rheumatologists.”         … Read More »Q&A with MPN Pioneer Andrew Schafer, MD

    READ MORE

    Current and emerging therapies

    Philadelphia-negative myeloproliferative neoplasms (MPNs), including essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF), are hematologic malignancies characterized by the abnormal proliferation of blood cells in the bone marrow. MPNs cause significant morbidity in the form of burdensome symptoms, potentially fatal cardiovascular complications, progression to more aggressive disease, and over time, can evolve to… Read More »Current and emerging therapies

    READ MORE

    Q&A with Dr. Ruben Mesa

    Dr. Ruben Mesa on his move to Wake Forest Baptist Comprehensive Cancer Center MPN patients are asking about your recent move from MD Anderson to Levine Cancer Center/Wake Forest Health. How would you describe the impact of your move?   I am excited to be joining two wonderful MPN teams already well established – in Charlotte… Read More »Q&A with Dr. Ruben Mesa

    READ MORE

    Just Published NUTRIENT Trial: Mediterranean Diet Intervention in MPNs

    Just Published NUTRIENT Trial: Mediterranean Diet Intervention in MPNs The Mediterranean diet has long been associated with disease fighting anti-inflammatory benefits. In recent years, it has become a standard component of care for the prevention and management of many chronic conditions, such as cardiovascular disease. It has not yet entered the treatment algorithm for MPNs,… Read More »Just Published NUTRIENT Trial: Mediterranean Diet Intervention in MPNs

    READ MORE

    Targeting the JAK2V617F hematopoietic stem cell through integrins-based combination

    Advancing Research: Targeting the JAK2V617F Hematopoietic Stem Cell Through Integrins-Based Combination Early in her career, as a veterinarian, Shinobu Matsuura, DVM, PhD, remembers a debilitating case of aplastic anemia in a young German shepherd. It pulled on her heart strings and solidified her belief that bone marrow is the most important organ in the body. … Read More »Targeting the JAK2V617F hematopoietic stem cell through integrins-based combination

    READ MORE

    2023 ASCO Annual Meeting MPN Highlights

    MPNs More Visible Than Ever at ASCO 2023  Recognized as the premier educational and scientific event for the greater oncology community, MPN presentations and posters were more prominent than ever at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.   MPNRF’s presence at ASCO was all encompassing. Our team was there to… Read More »2023 ASCO Annual Meeting MPN Highlights

    READ MORE

    2023 European Hematology Congress MPN Highlights

    2023 European Hematology Congress MPN Highlights The European Hematology Association (EHA) Congress 2023 in Frankfurt, Germany in June, brought more than 10,000 participants together, with a much higher representation of MPN research and clinical advances than in previous years.   In one major session, presentations by leaders of an MPN specialized working group represented the work… Read More »2023 European Hematology Congress MPN Highlights

    READ MORE

    Benefits of Giving to MPN Research in Your Will

    It’s not something most of us think about, but including in your will a gift to a cause you care about, like MPN Research Foundation, has personal benefits for you long before your assets are distributed as you wish.  Four benefits you can collect on now: Lessening anxiety. Thinking and planning ahead can make it… Read More »Benefits of Giving to MPN Research in Your Will

    READ MORE

    AACR Annual Meeting MPN Highlights

    While the Annual Meeting of the American Association for Cancer Research (AACR), held in April 2023, focused a great deal on understanding, decoding, and advocating for cancer health equity and inclusion, there were also significant scientific take-aways important to the treatment of MPNs.  One presentation by Haris Ali, MD, City of Hope Comprehensive Cancer Center,… Read More »AACR Annual Meeting MPN Highlights

    READ MORE

    1 2 3 4 5 43
  • Join the MPN Research community

    Be the first to know about the latest news and advancements.
    What are the latest developments in MPN Research?